ES2625294T3 - Suplemento alimenticio biológicamente activo - Google Patents
Suplemento alimenticio biológicamente activo Download PDFInfo
- Publication number
- ES2625294T3 ES2625294T3 ES10751072.9T ES10751072T ES2625294T3 ES 2625294 T3 ES2625294 T3 ES 2625294T3 ES 10751072 T ES10751072 T ES 10751072T ES 2625294 T3 ES2625294 T3 ES 2625294T3
- Authority
- ES
- Spain
- Prior art keywords
- vitamin
- leuzea
- ascorbic acid
- food supplement
- excipients
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000015872 dietary supplement Nutrition 0.000 title claims abstract description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 26
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 16
- 238000009395 breeding Methods 0.000 claims abstract description 15
- 230000001488 breeding effect Effects 0.000 claims abstract description 15
- 241001306755 Leuzea Species 0.000 claims abstract description 11
- 235000010323 ascorbic acid Nutrition 0.000 claims abstract description 9
- 239000011668 ascorbic acid Substances 0.000 claims abstract description 9
- 229960005070 ascorbic acid Drugs 0.000 claims abstract description 9
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 8
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000000546 pharmaceutical excipient Substances 0.000 claims abstract description 8
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 8
- 229940046009 vitamin E Drugs 0.000 claims abstract description 8
- 239000011709 vitamin E Substances 0.000 claims abstract description 8
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims abstract description 6
- 239000008101 lactose Substances 0.000 claims abstract description 6
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 claims abstract description 5
- 235000013539 calcium stearate Nutrition 0.000 claims abstract description 5
- 239000008116 calcium stearate Substances 0.000 claims abstract description 5
- 239000000454 talc Substances 0.000 claims abstract description 5
- 229910052623 talc Inorganic materials 0.000 claims abstract description 5
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 4
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 4
- 239000011718 vitamin C Substances 0.000 claims abstract description 4
- 239000000203 mixture Substances 0.000 description 9
- 210000003205 muscle Anatomy 0.000 description 8
- 239000000047 product Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 5
- 230000001195 anabolic effect Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 235000012222 talc Nutrition 0.000 description 3
- ZAKOWWREFLAJOT-UHFFFAOYSA-N DL-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- 241000241413 Propolis Species 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 229940069949 propolis Drugs 0.000 description 2
- 210000002307 prostate Anatomy 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000021642 Muscular disease Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 229940030486 androgens Drugs 0.000 description 1
- 229940085398 ascorbic acid 50 mg Drugs 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229940078456 calcium stearate Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000009956 central mechanism Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- -1 for example Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229960001375 lactose Drugs 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 229930195732 phytohormone Natural products 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000035936 sexual power Effects 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000003270 steroid hormone Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 229940033134 talc Drugs 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- 235000008210 xanthophylls Nutrition 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/06—Anabolic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Insects & Arthropods (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Botany (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Neurology (AREA)
- Endocrinology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Animal Husbandry (AREA)
- Medical Informatics (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Reproductive Health (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
Abstract
Suplemento alimenticio que contiene leuzea, ácido ascórbico (Vitamina C) y Vitamina E y excipientes (estearato de calcio, talco, lactosa), que difiere en que contiene cría de abeja macho con la siguiente proporción de componentes (% en masa): Cría de abeja macho 1-70; Leuzea 5-70; Ácido ascórbico 1-70; Vitamina E 0,05 - 30; Excipientes- el resto.
Description
5
10
15
20
25
30
SUPLEMENTO ALIMENTICIO BIOLOGICAMENTE ACTIVO
Description
Esta invention se refiere a la industria alimentaria, en particular, a complementos alimenticios, destinados a aumentar la masa muscular de los atletas.
Los mejores bioestimulantes y productos ricos en energia comprenden los preparados desarrollados sobre la base de productos apicolas. Existe un preparado conocido "Tonus" TU-6402-06-244-91 desarrollado a base de polen de flores y lactosa, y aprobado por el Jefe del Departamento Sanitario del Presidente de la Federation Rusa, que es producido por BIOCOR. Sin embargo, este preparado no contiene un complejo multivitammico y microelementos vitales. Su efecto en el cuerpo humano esta gobernado unicamente por el polen de las flores, lo que puede obstaculizar la comprension de la actividad biologica de "Tonus", ya que es necesario saber con precision cuando se recoge el polen y de que plantas.
El documento RU 2 233 666 C1 muestra una composition que se utiliza como composition anabolica. La composicion comprende cria de abeja macho como agente activo.
El documento DE 196 27 627 A1 describe una composicion que comprende un extracto de cria de abeja macho. La composicion puede usarse topicamente para el tratamiento de enfermedades musculares.
Lo mas proximo a la invencion por la sustancia tecnica y el resultado conseguido es el complejo multivitammico natural "Leveton", Patente RU 2066963 C1 (IPC A23L001 / 076). Contiene el polen de las flores (carga de polen), leuzea, acido ascorbico, acetato de a-tocoferol, propoleo, estearato de calcio, talco y lactosa con la siguiente relation de componentes (% en masa): polen de flores (carga de polen) 50-51, leuzea 10, acido ascorbico 3,0-3,5, acetato de a-tocoferol 0,15, propoleo 2, estearato de calcio 0,92-0,95, talco 3, lactosa - el resto. "Leveton" se desarrolla para aumentar las propiedades de resistencia de los atletas y la masa muscular, y ha sido utilizado activamente por las escuelas de mayor deportividad durante mas de 10 anos. El efecto "Leveton" esta condicionado por la sinergia de sus componentes: concretamente vitaminas dosificadas y donantes de fitoecdisteroides, a saber, leuzea y polen de la flor (carga del polen).
En la invencion propuesta, se sugiere que el polen de las flores (carga de polen) sea sustituido por cria de abeja macho, una sustancia que posee un efecto anabolico mas fuerte que el polen de las flores, sirve como un farmaco natural que permite aumentar la masa muscular, protege los musculos de danos bioquimicos y logra los maximos resultados.
La cria de abeja macho difiere del polen de las flores por un mayor numero de grupos funcionales de enzimas de sulfuro, asi como hormonas, a saber, testosterona, progesterona y estradiol. Gracias
5
10
15
20
25
30
a este conjunto de sustancias, la cria de abeja macho promueve una mayor restauracion de las caracteristicas bioqmmicas y de masa metrica de la glandula mamaria y la glandula prostatica, siendo un estimulante de los mecanismos centrales reguladores de la intensidad de la formation de androgenos.
Composition qmmica: proteinas 10-20%; carbohidratos 1-5,5%; grasas 5-6,3%; aminoacidos 11,4%; glucosa 3,18-5%; fructosa y sacarosa hasta 0,5%.
Microelementos (% mg): K 0,50, Na 38, Ca 14, P 189, Mg 2, Fe 3,23, Mn 4,40%, Zn 5,54, Cu 2,
Cr, Co, Ni, Ag, Au y otros.
Vitaminas (agua y liposolubles): A 0,54 UI / g; xantofila 0,297 mg%; B - carotina 0,426 UI / g;
B2 0,739 mg%; D 950 UI / g; colina 442,8 mg%; acido nicotmico 15,8 mg%.
La cria de abeja macho aumenta el nivel del metabolismo durante el periodo de actividad muscular activa debido a que aumenta la resistencia fisica. La cria de abeja macho contiene 10 veces mas hormonas esteroides en comparacion con el polen de las flores.
A dia de hoy, "Leveton" no cumple con los requisitos actuales para el rapido crecimiento de la masa muscular de los atletas, no asegura la recuperation rapida de los musculos fatigados despues de una carga fisica dura. La invention propuesta hace que el proceso de recuperation de un atleta sea mas corto en comparacion con un prototipo a expensas de un mayor contenido de fitoecdisteroides.
El resultado tecnico anterior se consigue debido a que la cria de abeja macho se introduce adicionalmente en el conocido producto terapeutico-profilactico "Leveton" que contiene leuzea, acido ascorbico (Vitamina C) y Vitamina E y excipientes, y la carga de polen se elimina de su composicion con la siguiente proportion de componentes (% en masa):
Cria de abeja macho 1-70;
Leuzea 5-70;
Acido ascorbico 1-70;
Vitamina E 0,05 - 30;
Excipientes- el resto
Como excipientes, se puede usar, por ejemplo, estearato de calcio 0,92-0,95, talco 3-6, lactosa - el resto.
En el proceso de busqueda por fuentes de information cientifico-tecnica y de patentes, no se encontro ninguna sustancia que posea un agregado similar de caracteristicas esenciales con el mismo efecto positivo conseguido. As^ la invention propuesta presenta una solution tecnica de la tarea, posee novedad, nivel inventivo y utilidad industrial. El producto terapeutico-profilactico se fabrica en forma de comprimido. Se determina un nivel inferior por conveniencia de uso del
complejo propuesto, es dedr, el uso de un numero menor de comprimidos. Se determina un nivel superior por el hecho de que, en caso de un mayor porcentaje de proportion, sera dificil fabricar un comprimido, ya que se descompondra.
Ejemplo 1
5 Un ejemplo de la formulation de mezcla para una tableta de masa 500 g:
Cria de abeja macho 10 mg Leuzea 50 mg
Acido ascorbico 50 mg
Vitamina E 5 mg
10 Excipientes 385 mg
Por lo tanto, el suplemento alimenticio propuesto desarrollado sobre la base de extractos de leuzea, cria de abeja macho, acido ascorbico (Vitamina C), Vitamina E, puede utilizarse como un producto para el crecimiento de la masa muscular de los atletas debido a un mayor contenido de 15 fitoecdisteroides, fitohormonas que influyen en el proceso anabolico en el cuerpo de un atleta.
El producto no solo produce un efecto anabolico en el cuerpo humano, sino que se recomienda para la profilaxis de disfunciones del sistema nervioso central, el tratamiento de enfermedades de la glandula prostatica y tambien la perdida de poder sexual.
Claims (1)
- Reivindicaciones1. Suplemento alimenticio que contiene leuzea, acido ascorbico (Vitamina C) y Vitamina E y excipientes (estearato de calcio, talco, lactosa), que difiere en que contiene cria de abeja macho con la siguiente proportion de componentes (% en masa):5 Cria de abeja macho 1-70;Leuzea 5-70;Acido ascorbico 1-70;Vitamina E 0,05 - 30;Excipientes- el resto.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2009109273/13A RU2390270C1 (ru) | 2009-03-13 | 2009-03-13 | Биологически активная добавка к пище |
RU2009109273 | 2009-03-13 | ||
PCT/RU2010/000098 WO2010104418A1 (ru) | 2009-03-13 | 2010-03-03 | Биологически активная добавка к пище |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2625294T3 true ES2625294T3 (es) | 2017-07-19 |
Family
ID=42680298
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES10751072.9T Active ES2625294T3 (es) | 2009-03-13 | 2010-03-03 | Suplemento alimenticio biológicamente activo |
Country Status (12)
Country | Link |
---|---|
US (3) | US20120003200A1 (es) |
EP (1) | EP2407035B1 (es) |
CN (1) | CN102791149B (es) |
CA (1) | CA2793071C (es) |
DK (1) | DK2407035T3 (es) |
EA (1) | EA019184B1 (es) |
ES (1) | ES2625294T3 (es) |
LT (1) | LT2407035T (es) |
PL (1) | PL2407035T3 (es) |
RU (1) | RU2390270C1 (es) |
UA (1) | UA108465C2 (es) |
WO (1) | WO2010104418A1 (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2414229C1 (ru) * | 2009-10-12 | 2011-03-20 | Общество С Ограниченной Ответственностью "Парафарм" | Лекарственное средство для профилактики и лечения аденомы и простатита |
RU2425593C1 (ru) * | 2010-05-04 | 2011-08-10 | Общество С Ограниченной Ответственностью "Парафарм" | Биологически активная добавка к пище для нормализации уровня андрогенов мужчин, общего состояния, снижения ожирения |
RU2458537C1 (ru) * | 2011-03-14 | 2012-08-20 | Общество С Ограниченной Ответственностью "Парафарм" | Биологически активная добавка к пище для профилактики эректильной дисфункции у мужчин |
RU2456005C1 (ru) * | 2011-04-20 | 2012-07-20 | Общество с ограниченной ответственностью фирма "Биокор" | Способ приготовления биологически активного препарата |
RU2509569C2 (ru) * | 2011-07-05 | 2014-03-20 | Общество С Ограниченной Ответственностью "Парафарм" | Композиция для лечения и предупреждения остеоартрита и остеоартроза суставов |
RU2493733C2 (ru) * | 2011-07-05 | 2013-09-27 | Общество С Ограниченной Ответственностью "Парафарм" | Тонизирующий напиток |
RU2491078C2 (ru) * | 2011-09-16 | 2013-08-27 | Общество С Ограниченной Ответственностью "Парафарм" | Способ приготовления расплода трутневого адсорбированного и его состав |
RU2561863C1 (ru) * | 2014-03-12 | 2015-09-10 | Автономная некоммерческая организация содействия социально-экономическому развитию "ИНЖЭКОН-Тверь" | Способ изготовления биологического стимулятора |
US9700589B2 (en) * | 2015-02-03 | 2017-07-11 | Naturex Sa | Compositions and methods for improved muscle metabolism |
RU2577225C1 (ru) * | 2015-03-27 | 2016-03-10 | Общество С Ограниченной Ответственностью "Парафарм" | Препарат и способ для лечения дефицита андрогенов у женщин, содержащий энтомологические протеины |
FR3078252B1 (fr) * | 2018-02-28 | 2020-08-14 | Biophytis | Phytoecdysones pour leur utilisation dans la prevention de la perte de force musculaire lors d’une immobilisation |
RU2679361C1 (ru) * | 2018-03-29 | 2019-02-07 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Воронежский государственный университет инженерных технологий" (ФГБОУ ВО "ВГУИТ") | Способ получения биогенного стимулятора для коррекции иммунного статуса сельскохозяйственных животных |
RU2745997C1 (ru) * | 2019-11-28 | 2021-04-05 | Общество с ограниченной ответственностью "Фармацевтический завод "ГАЛЕН" | Биологически активная композиция, обладающая адаптогенным и антистрессорным действием |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1028200C (zh) * | 1988-09-07 | 1995-04-19 | 刘本华 | 雄蜂营养素的提取方法 |
RU1826910C (ru) * | 1991-05-12 | 1993-07-07 | В.А.Чуйко и Г.Н.Спиридонова | Биостимулирующее средство |
RU2066963C1 (ru) * | 1993-10-20 | 1996-09-27 | Рошен Джафарович Сейфулла | Натуральный поливитаминный комплекс "леветон" |
CN1097308A (zh) * | 1994-04-13 | 1995-01-18 | 唐国山 | 雄蜂神液 |
DE19627627C2 (de) * | 1996-07-09 | 2003-06-18 | Bienenzell Gmbh | Verfahren zur Herstellung eines Bienenbrutsaft-Extraktes |
RU2149566C1 (ru) * | 1997-11-19 | 2000-05-27 | Сейфулла Рошен Джафарович | Натуральный поливитаминный комплекс "астенотон" |
CN1274319C (zh) * | 2000-07-18 | 2006-09-13 | 沈阳药科大学 | 中药漏芦中植物甾酮类成分的用途 |
RU2216346C1 (ru) * | 2002-06-10 | 2003-11-20 | Семенова Наталья Викторовна | Средство и способ для биогенной стимуляции организма |
RU2233666C1 (ru) * | 2002-12-30 | 2004-08-10 | Пятигорская государственная фармацевтическая академия | Таблетки "апилар" на основе трутневого расплода, обладающие анаболическим, актопротекторным действием |
-
2009
- 2009-03-13 RU RU2009109273/13A patent/RU2390270C1/ru active
-
2010
- 2010-03-03 CA CA2793071A patent/CA2793071C/en active Active
- 2010-03-03 PL PL10751072T patent/PL2407035T3/pl unknown
- 2010-03-03 WO PCT/RU2010/000098 patent/WO2010104418A1/ru active Application Filing
- 2010-03-03 LT LTEP10751072.9T patent/LT2407035T/lt unknown
- 2010-03-03 ES ES10751072.9T patent/ES2625294T3/es active Active
- 2010-03-03 CN CN201080011447.9A patent/CN102791149B/zh not_active Expired - Fee Related
- 2010-03-03 DK DK10751072.9T patent/DK2407035T3/en active
- 2010-03-03 EP EP10751072.9A patent/EP2407035B1/en active Active
- 2010-03-03 EA EA201100167A patent/EA019184B1/ru unknown
- 2010-03-03 UA UAA201103548A patent/UA108465C2/ru unknown
- 2010-03-03 US US13/256,237 patent/US20120003200A1/en not_active Abandoned
-
2013
- 2013-12-23 US US14/138,875 patent/US20140314870A1/en not_active Abandoned
-
2016
- 2016-03-06 US US15/062,161 patent/US10064421B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP2407035A4 (en) | 2013-01-02 |
US20160192687A1 (en) | 2016-07-07 |
EA019184B1 (ru) | 2014-01-30 |
CN102791149B (zh) | 2015-05-27 |
CN102791149A (zh) | 2012-11-21 |
LT2407035T (lt) | 2017-04-10 |
US20120003200A1 (en) | 2012-01-05 |
EP2407035A1 (en) | 2012-01-18 |
EA201100167A1 (ru) | 2011-06-30 |
DK2407035T3 (en) | 2017-04-10 |
PL2407035T3 (pl) | 2017-07-31 |
US20140314870A1 (en) | 2014-10-23 |
RU2390270C1 (ru) | 2010-05-27 |
CA2793071A1 (en) | 2010-09-16 |
EP2407035B1 (en) | 2017-02-22 |
UA108465C2 (en) | 2015-05-12 |
CA2793071C (en) | 2018-11-13 |
US10064421B2 (en) | 2018-09-04 |
WO2010104418A1 (ru) | 2010-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2625294T3 (es) | Suplemento alimenticio biológicamente activo | |
JP2007028997A (ja) | 生薬エキス配合流動食及びその使用 | |
PH12017550006A1 (en) | Optimized nutrient fatty acid composition | |
CN101283797B (zh) | 以核桃油为基质的促智健脑保健品 | |
ES2637963T3 (es) | Suplemento alimenticio biológicamente activo para normalizar el nivel de andrógeno en hombres y el estado general y para reducir la obesidad | |
RU2376888C2 (ru) | Биологически активная добавка к пище | |
CN103583461B (zh) | 一种提高鸡蛋中钙含量的生产方法 | |
RU2625738C1 (ru) | Способ получения интимного пантового крема для женщин | |
CN105901163A (zh) | 补钙保健山茶油及其制备方法 | |
CN111315238A (zh) | 用于减轻由衰老引起的女性病症的补充剂 | |
CN103478074A (zh) | 一种补肾功能强化鸡蛋的生产方法 | |
RU2216204C2 (ru) | Способ подготовки семян для приготовления пищевых проростков | |
Talib et al. | Therapeutic dose of madidihang fish bone flour and CaCO3 towards calcium and phosphorus content in blood serum and bones of ovariectomy rat | |
IT202000006550A1 (it) | Composizione a base di mieli e suo uso quale integratore alimetare o cosmetico | |
CN103479685A (zh) | 一种足浴液 | |
DE202013004122U1 (de) | Multivitamin- und Energiepille | |
WO2006043802A1 (es) | Fórmula antiestresante para uso humano y veterinario | |
CN104431348A (zh) | 一种预防白玉蜗牛顶壳脱落的饲料添加剂 | |
KR200325848Y1 (ko) | 프로폴리스 추출물을 첨가한 남녀 팬티 | |
van Schie | A pause in proceedings | |
BG1733U1 (bg) | Биостимулиращ състав от пчелни продукти | |
Vassileva | Developing compositions of medicinal plants, intended for use as additives to enrich drinks, concentrates and sauces | |
CN102067945A (zh) | 一种健身鸡蛋 | |
Chaudhary et al. | Medicinal Value of Flax Seed | |
UA119952C2 (uk) | Склад масляної суміші |